NS Wind Down Co Inc (NSTGQ)
0.10
-0.01
(-8.00%)
USD |
OTCM |
May 31, 16:00
NS Wind Down Cash from Investing (Quarterly): -1.916M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -1.916M |
June 30, 2023 | 24.31M |
March 31, 2023 | 43.80M |
December 31, 2022 | 24.11M |
September 30, 2022 | 27.71M |
June 30, 2022 | 59.97M |
March 31, 2022 | 20.70M |
December 31, 2021 | 16.61M |
September 30, 2021 | -26.55M |
June 30, 2021 | -222.97M |
March 31, 2021 | 12.69M |
December 31, 2020 | 29.85M |
September 30, 2020 | 19.06M |
June 30, 2020 | 32.49M |
March 31, 2020 | 9.841M |
December 31, 2019 | 22.19M |
September 30, 2019 | 6.26M |
June 30, 2019 | -54.86M |
March 31, 2019 | 11.26M |
December 31, 2018 | 2.57M |
September 30, 2018 | -48.77M |
June 30, 2018 | 17.90M |
March 31, 2018 | 5.374M |
December 31, 2017 | 8.995M |
Date | Value |
---|---|
September 30, 2017 | -2.79M |
June 30, 2017 | -7.852M |
March 31, 2017 | -0.843M |
December 31, 2016 | -11.56M |
September 30, 2016 | -5.799M |
June 30, 2016 | -12.08M |
March 31, 2016 | -0.828M |
December 31, 2015 | -0.432M |
September 30, 2015 | 7.665M |
June 30, 2015 | 3.389M |
March 31, 2015 | 13.15M |
December 31, 2014 | -6.954M |
September 30, 2014 | 9.531M |
June 30, 2014 | -2.505M |
March 31, 2014 | -24.35M |
December 31, 2013 | 0.551M |
September 30, 2013 | -33.25M |
June 30, 2013 | -0.118M |
March 31, 2013 | -0.136M |
December 31, 2012 | -0.116M |
September 30, 2012 | -0.089M |
June 30, 2012 | -0.091M |
March 31, 2012 | -0.132M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-222.97M
Minimum
Jun 2021
59.97M
Maximum
Jun 2022
2.405M
Average
19.88M
Median
Cash from Investing (Quarterly) Benchmarks
Bruker Corp | -304.20M |
Azenta Inc | -270.61M |
Harvard Bioscience Inc | -0.225M |
Bionano Genomics Inc | 47.59M |
Akoya Biosciences Inc | -48.82M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -19.70M |
Cash from Financing (Quarterly) | 0.822M |
Free Cash Flow | -135.74M |
Free Cash Flow Per Share (Quarterly) | -0.453 |
Free Cash Flow to Equity (Quarterly) | -22.00M |
Free Cash Flow to Firm (Quarterly) | -21.07M |
Free Cash Flow Yield | -2.88K% |